DBTX

Decibel Therapeutics Expands World-Class Scientific Advisory Board

Decibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate Update

Decibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference

Decibel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update

Decibel Therapeutics' Hearing Loss Gene Therapy Shows Potential In Preclinical Studies

Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations

Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference